Menu Close

Summary*

PatientPop, founded in 2014 and headquartered in Santa Monica, California, is a practice growth technology platform for healthcare providers. The company aims to enhance and automate various touchpoints in the patient journey, from initial online impressions and digital booking to post-appointment follow-ups. In November 2021, PatientPop merged with Kareo to form Tebra, marking a significant milestone in the company's growth trajectory.

Since its inception, PatientPop has successfully raised a total of $97.86 million in funding, demonstrating investor confidence in its business model and potential for growth. The company's innovative approach to healthcare practice management has positioned it as a notable player in the healthcare technology sector.

As of now, there is no concrete information available regarding PatientPop's IPO prospects. The company has not made any official announcements about plans to go public, and we have not found any credible reports or rumors suggesting an imminent IPO. It's important to note that the decision to pursue an initial public offering depends on various factors, including market conditions, company performance, and strategic objectives.

Investors interested in PatientPop or similar companies in the healthcare technology sector should continue to monitor official company announcements and reliable financial news sources for any updates on potential IPO plans. As always, it's crucial to conduct thorough research and consider the risks associated with investing in private companies before making any investment decisions.

How to invest in PatientPop

While PatientPop's IPO prospects remain uncertain, investors eager to gain exposure to innovative healthcare technology companies don't have to wait. At Linqto, we offer members access to interests in pre-IPO private companies, including potential leaders in the healthcare tech sector. Our platform allows you to diversify your portfolio with lower minimum investments in promising companies like PatientPop, potentially benefiting from their growth before they go public.

*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.